Skip to main content
Fig. 1 | BMC Infectious Diseases

Fig. 1

From: Estimating effects of intervention measures on COVID-19 outbreak in Wuhan taking account of improving diagnostic capabilities using a modelling approach

Fig. 1

The daily number of new COVID-19 documented (reported) cases by date and the timeline of improved diagnostic capability and transportation restrictions implemented in Wuhan, China. Wuhan transportation restrictions were implemented on January 23 [15]; New commercial kits were approved by the State Food and Drug Administration (SFDA) on January 26 [18]; Updated diagnostic criteria, i.e. COVID-19 case confirmation should rely on both clinical diagnosis and laboratory diagnosis, was introduced on February 12 [16]. A break was made in the y-axis, and the narrow grey horizontal bar indicates where the break was set

Back to article page